• Methicillin Sodium Salt in MSSA Research

  2026-08-26

  Build reproducible MSSA susceptibility assays, infection models, and resistance controls with Methicillin sodium salt. This workflow pairs a mechanism-matched bacterial cell wall synthesis inhibitor with quantitative MIC, time-kill, and genotype-aware interpretation.

• Norepinephrine Bitartrate in Renal Hemodynamics

  2026-08-26

  (-)-Norepinephrine (+)-bitartrate is more than a vasopressor reference compound: it can expose how disease state, vascular potassium channels, and assay scale reshape adrenergic responses. This article translates renal perfusion findings into practical decisions for cardiovascular and cardiomyopathy research.

• E-4031 for 3D Cardiac Electrophysiology

  2026-08-25

  E-4031 combines potent hERG inhibition with a practical workflow for exposing arrhythmogenic phenotypes in cardiac organoids. Paired with shell microelectrode arrays, it supports 3D mapping of repolarization, conduction, and drug-induced instability rather than relying on planar or single-cell readouts alone.

• Coumestrol: From Nuclear Receptors to RA Ferroptosis

  2026-08-25

  Coumestrol links estrogen receptor pharmacology with ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes, offering translational researchers a framework for separating receptor activity, cellular mechanism, and therapeutic relevance.

• Esculin in Renal Cell Carcinoma: Mechanism and Evidence

  2026-08-24

  Chen et al. combined network pharmacology, molecular docking, and cell-based validation to investigate how esculin may act against renal cell carcinoma. Their results implicate GAPDH and PI3K/Akt signaling in reduced proliferation and migration and increased apoptosis, while also defining important limitations for translating these findings beyond in vitro models.

• Stat3 in Fyn-Driven Dopaminergic Neurodegeneration

  2026-08-24

  A 2024 zebrafish study identifies Stat3 as a key downstream effector of constitutively active Fyn signaling in dopaminergic neuron loss and microglial inflammation. Its combination of neural-specific genetics, live imaging, transcriptomics, and pathway inhibition provides a mechanistic framework for studying neurodegeneration and inflammatory signaling in vivo.

• Zoledronic Acid Workflows for Cancer Research

  2026-08-23

  Build more reproducible cancer cell apoptosis assays and bone-disease studies with a controlled Zoledronic Acid workflow. This guide connects dose–time screening, solubility management, apoptosis readouts, and the 5T2MM myeloma model while clearly separating established product data from practical optimization recommendations.

• METTL16-SENP3-LTF Axis in HCC Ferroptosis

  2026-08-22

  Wang et al. identify an m6A-dependent METTL16-SENP3-LTF pathway that limits labile iron and protects hepatocellular carcinoma cells from ferroptosis. By integrating cell, organoid, mouse-model, biochemical, and human-sample evidence, the study provides a mechanistic basis for sensitizing HCC to ferroptosis-oriented treatment.

• Cyclosporin A (B1922): Protocol and QC Guide

  2026-08-21

  Cyclosporin A (B1922) provides a practical cyclophilin-inhibition tool for immune signaling, apoptosis modulation, mitochondrial studies, and selected viral or retinal injury models. It is appropriate for controlled cell and animal research workflows, but should not be used in aqueous protocols or without model-specific validation of concentration, exposure, formulation, and tolerability.

• Lithium, Exosomal Wnt10a, and Bone Repair

  2026-08-20

  The 2024 ACS Applied Materials & Interfaces study identifies a Rab11a–Rab11FIP1 trafficking mechanism by which lithium increases exosomal Wnt10a secretion from bone mesenchymal stem cells. Lithium-conditioned exosomes enhanced osteogenic differentiation, and their incorporation into GelMA hydrogels improved bone repair, providing a mechanistic framework for engineering cell-free regenerative therapies.

• MTT for HUVEC Viability and Angiogenesis Studies

  2026-08-20

  Use MTT to quantify HUVEC metabolic activity while pairing it with tube formation, migration, and pathway readouts for a more complete angiogenesis workflow. This guide translates findings from a critical limb ischemia study into practical assay design, optimization, and troubleshooting decisions.

• FLAG tag Peptide: Assay Design for Clean Elution

  2026-08-19

  The FLAG tag Peptide and DYKDDDDK peptide support gentle affinity elution while preserving recombinant protein function. This guide connects tag-based workflow design with the mechanistic assay lessons of a landmark Sin3L/Rpd3L HDAC study.

• Cy5.5 NHS Ester for Biodistribution Assays

  2026-08-19

  Cy5.5 NHS ester enables covalent near-infrared labeling of amine-containing biomolecules for biodistribution and in vivo fluorescence imaging. This guide connects dye chemistry with a 2025 polysaccharide absorption study to clarify tracer design, controls, and interpretation.

• KN-62: CaMKII Control for Translational Biology

  2026-08-18

  KN-62 offers a focused way to interrogate CaMKII within calcium-dependent signaling, metabolism, secretion, and cell-cycle biology. This thought-leadership perspective connects its established research applications with recent findings on calcium-driven autophagy in glioblastoma while clearly separating validated evidence from forward-looking experimental strategy.

• Bergenin–PPARγ–PROX1 Axis in Psoriasis

  2026-08-18

  A 2026 Phytomedicine study identifies bergenin as a plant-derived PPARγ agonist that suppresses pathogenic γδT17 cells in psoriasis models. Its central mechanistic contribution is linking PPARγ activation to PROX1 ubiquitination at K248, reduced fatty acid oxidation, epigenetic repression of IL17A, and lower psoriatic inflammation.

8505 records 1/567 page Next 12345 下5页 Last page